Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum ; volume:15 ; number:1 ; day:5 ; month:7 ; year:2023 ; pages:1-8 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (5.7.2023), 1-8, 12.2023

Creator: Dubbelman, Mark A.
Mimmack, Kayden J.
Sprague, Emily H.
Amariglio, Rebecca E.
Vannini, Patrizia
Marshall, Gad A.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-023-01267-w

URN: urn:nbn:de:101:1-2023100408304927223011

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Dubbelman, Mark A.
Mimmack, Kayden J.
Sprague, Emily H.
Amariglio, Rebecca E.
Vannini, Patrizia
Marshall, Gad A.
SpringerLink (Online service)

Other Objects (12)

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Related objects

Reset password